Debel Marlene's most recent trade in Metlife Inc was a trade of 2,866 Common Stock done at an average price of $85.7 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.70 per share. | 03 Mar 2025 | 2,866 | 134,135 (0%) | 0% | 85.7 | 245,616 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 28,426 | 149,707 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 12,774 | 121,281 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.20 per share. | 25 Feb 2025 | 12,706 | 137,001 (0%) | 0% | 82.2 | 1,044,433 | Common Stock |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 1,711 | 1,253 | - | - | Restricted Stock Units | |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2025 | 1,711 | 7,567 (0%) | 0% | 0 | Common Stock | |
| Raymond James Financial | Marlene Debel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,253 | 2,964 | - | - | Restricted Stock Units | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 82.88 per share. | 13 Dec 2024 | 22,810 | 108,507 (0%) | 0% | 82.9 | 1,890,577 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.33 per share. | 13 Dec 2024 | 13,107 | 121,614 (0%) | 0% | 34.3 | 449,963 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 13,107 | 0 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.91 per share. | 13 Dec 2024 | 9,703 | 131,317 (0%) | 0% | 45.9 | 445,465 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 9,703 | 0 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.73 per share. | 01 Mar 2024 | 2,741 | 108,507 (0%) | 0% | 69.7 | 191,130 | Common Stock |
| MetLife | Debel Marlene | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 35,957 | 127,454 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 17,896 | 17,896 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.16 per share. | 27 Feb 2024 | 16,206 | 111,248 (0%) | 0% | 69.2 | 1,120,807 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 5,965 | 91,497 (0%) | 0% | - | Common Stock | |
| Raymond James Financial | Marlene Debel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 1,711 | 3,354 | - | - | Restricted Stock Units | |
| Raymond James Financial | Debel Marlene | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 1,643 | 5,856 (0%) | 0% | 0 | Common Stock | |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 1,643 | 1,711 | - | - | Restricted Stock Units | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 7,894 | 85,532 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 10,911 | 0 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.15 per share. | 09 Aug 2023 | 10,911 | 87,029 (0%) | 0% | 45.2 | 492,632 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 63.18 per share. | 09 Aug 2023 | 9,391 | 77,638 (0%) | 0% | 63.2 | 593,323 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 32,193 | 93,034 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 16,625 | 16,625 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.73 per share. | 28 Feb 2023 | 14,368 | 78,666 (0%) | 0% | 71.7 | 1,030,617 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 5,542 | 60,841 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.27 per share. | 28 Feb 2023 | 2,548 | 76,118 (0%) | 0% | 71.3 | 181,596 | Common Stock |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 1,683 | 4,213 (0%) | 0% | 0 | Common Stock | |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 1,683 | 1,643 | - | - | Restricted Stock Units | |
| Raymond James Financial | Marlene Debel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,643 | 3,326 | - | - | Restricted Stock Units | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.15 per share. | 19 Aug 2022 | 5,513 | 59,359 (0%) | 0% | 31.2 | 171,730 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 5,513 | 0 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 67.60 per share. | 19 Aug 2022 | 4,060 | 55,299 (0%) | 0% | 67.6 | 274,456 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.44 per share. | 01 Mar 2022 | 1,811 | 53,846 (0%) | 0% | 64.4 | 116,701 | Common Stock |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2022 | 1,925 | 1,683 | - | - | Restricted Stock Units | |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2022 | 1,925 | 2,530 (0%) | 0% | 0 | Common Stock | |
| Raymond James Financial | Marlene Debel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 1,683 | 3,608 | - | - | Restricted Stock Units | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 15,986 | 15,986 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 11,313 | 59,755 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 5,330 | 48,442 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.96 per share. | 22 Feb 2022 | 4,098 | 55,657 (0%) | 0% | 69.0 | 282,598 | Common Stock |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 605 | 0 | - | - | Restricted Stock Units | |
| Raymond James Financial | Marlene Debel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 605 | 605 (0%) | 0% | 0 | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Sale of securities on an exchange or to another person at price $ 64.58 per share. | 11 May 2021 | 11,000 | 43,112 (0%) | 0% | 64.6 | 710,425 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.44 per share. | 01 Mar 2021 | 954 | 54,517 (0%) | 0% | 59.4 | 56,706 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.96 per share. | 01 Mar 2021 | 405 | 54,112 (0%) | 0% | 59.0 | 23,879 | Common Stock |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 15,674 | 15,674 | - | - | Employee Stock Options (right to buy) | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 7,914 | 58,179 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 5,224 | 50,265 (0%) | 0% | - | Common Stock | |
| MetLife | Marlene Debel | EVP & Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.43 per share. | 23 Feb 2021 | 2,708 | 55,471 (0%) | 0% | 57.4 | 155,520 | Common Stock |
| Raymond James Financial | Marlene Debel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 1,283 | 1,283 | - | - | Restricted Stock Units | |
| Raymond James Financial | Marlene Debel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 403 | 403 | - | - | Restricted Stock Units |